Here’s Why (and How) We Microdose Ozempic & Mounjaro with T1D
Send us Fan Mail Sixty-two percent of U.S. adults with type 1 diabetes are living with overweight or obesity. That’s nearly identical to the general population, according to a 2023 Johns Hopkins study published in Annals of Internal Medicine, and it shatters the old myth that T1D is a “thin person’s disease.”…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Diabetes Nerd →
GLP-1s Explained: Weight Loss, Side Effects, and What They Can Really Do
78%OZEMPIC Explicado por Endocrinóloga: la verdad que los médicos no siempre explican antes de recetar
GLP-1s: The Miracle Drug Changing Weight Loss & Medicine Forever (ft. Bracha Banayan) | SNH #116
#330 GLP-1s. Everything You Need to Know | Ashley Koff, RD
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.